# Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial

> **NCT02283346** · PHASE2 · UNKNOWN · sponsor: **AC Camargo Cancer Center** · enrollment: 60 (estimated)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **RADIATION:** HDR brachytherapy + hypofractionated EBRT

## Key facts

- **NCT ID:** NCT02283346
- **Lead sponsor:** AC Camargo Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02283346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02283346, "Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02283346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*